Pediatric Hepatology Program at Children’s Hospital of Pittsburgh of UPMC

Doctors at Children's Hospital of Pittsburgh of UPMC believe that the proper combination of medical and surgical therapy is the key to a successful outcome for children diagnosed with liver disease. They have recently launched two new clinical studies that may help combat the effects of liver disease. One studies ursodeoxycholic acid (URSO) for the treatment of primary sclerosing cholangitis and the other investigates the efficacy of carbamazepine in the treatment of A1AT deficiency.